MAPT and Alzheimer disease: aimed to develop theragnostic magnetic nanoparticles that can target tau proteins, thereby facilitating the diagnosis and treatment of AD.[130] The nanoparticles used in this study were constructed using Fe‐MIL‐88B‐NH2 as a base material.